Changes in mRNA Expression Levels of Solute Carrier Transporters in Inflammatory Bowel Disease Patients-Reference-Cited by-同舟云学术

Changes in mRNA Expression Levels of Solute Carrier Transporters in Inflammatory Bowel Disease Patients

Published:2009-06-01 Issue:9 Volume:37 Page:1871-1877
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Wojtal Kacper A.,Eloranta Jyrki J.,Hruz Petr,Gutmann Heike,Drewe Jürgen,Staumann Alex,Beglinger Christoph,Fried Michael,Kullak-Ublick Gerd A.,Vavricka Stephan R.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference27 articles.

1. Structure of renal organic anion and cation transporters

2. Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse

3. Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases

4. PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation

5. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated risk of adverse effects from foodborne contaminants and drugs in inflammatory bowel disease: a review;Archives of Toxicology;2024-09-09

2. Inflammation alters the expression pattern of drug transporters during Caco‐2 cell stimulation and azoxymethane‐induced colon tumorigenesis;Journal of Biochemical and Molecular Toxicology;2024-08-22

3. Intestinal absorption mechanism and nutritional synergy promotion strategy of dietary flavonoids: transintestinal epithelial pathway mediated by intestinal transport proteins;Critical Reviews in Food Science and Nutrition;2024-08

4. Downregulation of OATP2B1 by proinflammatory cytokines leads to 5-ASA hyposensitivity in Ulcerative colitis;Chemico-Biological Interactions;2024-08

5. The Effect of Inflammatory Bowel Disease and Irritable Bowel Syndrome on Pravastatin Oral Bioavailability: In vivo and in silico evaluation using bottom-up wbPBPK modeling;AAPS PharmSciTech;2024-04-11